A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated. Read more ...
Too many patient access strategies stop at “script filled”. But this approach is ultimately short-sighted, failing to build ...
The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...
Members of the public who spend a significant amount of time with chickens or other birds are being encouraged to sign up for ...
A trial of a potential mRNA vaccine against avian flu is starting in the UK as part of the country’s preparedness for a ...
Bird flu vaccine trial begins to fight ‘real possibility’ of virus threat for humans - The vaccine will utilise mRNA ...
Moderna has initiated a Phase 3 trial for its H5N1 bird flu vaccine, mRNA-1018. This marks the first late-stage human trial ...
Stringr on MSN
Britain trials mRNA vaccine as bird flu evolves
UK trials Moderna mRNA vaccine for evolving H5N1 clade 2.3.4.4b - 3,000 UK, 1,000 US people; poultry farmers urged ...
A first-of-its-kind trial has been launched to test a new vaccine for bird flu in humans. Thousands of people in the UK are ...
The vaccine, mRNA-1018, developed by Moderna, utilises mRNA technology similar to that employed in Covid-19 jabs ...
The jab targets the H5N1 flu strain which has caused devastating infections in bird populations worldwide, but has yet to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results